Alexandra Wright
Family Medicine · Quincy, FLNPI 1114587599
Payments from drug & device makers
Across 187 payments — averaging $20.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$790
- Pfizer$605
- AstraZeneca$303
- Boehringer Ingelheim$281
- AbbVie$193
- Supernus Pharmaceuticals, Inc.$154
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,744100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 35 | $790 |
| Pfizer | 39 | $605 |
| AstraZeneca | 17 | $303 |
| Boehringer Ingelheim | 13 | $281 |
| AbbVie | 11 | $193 |
| Supernus Pharmaceuticals, Inc. | 1 | $154 |
| Bayer | 9 | $150 |
| Sanofi-aventis U.S. LLC | 7 | $140 |
| Viiv Healthcare Company | 3 | $126 |
| E.r. Squibb & Sons, L.L.C. | 4 | $125 |
| Phathom Pharmaceuticals, Inc. | 6 | $99 |
| GSK | 5 | $90 |
| Exact Sciences | 5 | $87 |
| Lilly USA, LLC | 5 | $82 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| Vertex | 2 | $49 |
| Dexcom, Inc. | 1 | $34 |
| Amgen | 1 | $33 |
| Novartis | 2 | $33 |
| UCB, Inc. | 1 | $30 |
| Neurelis, Inc. | 2 | $29 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Organon | 1 | $20 |
| Global Blood Therapeutics, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
| Shionogi Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$154
How this compares
$3,744 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 82 | $81,417 |
| JardianceEmpagliflozin | 58 | $75,920 |
| MounjaroTirzepatide | 58 | $65,611 |
| RybelsusSemaglutide | 54 | $65,403 |
| EliquisApixaban | 39 | $50,495 |
| FarxigaDapagliflozin Propanediol | 46 | $49,224 |
| LinzessLinaclotide | 33 | $34,202 |
| JanuviaSitagliptin Phosphate | 31 | $30,884 |
| TrulicityDulaglutide | 24 | $30,067 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $21,009 |
| VraylarCariprazine Hcl | 13 | $20,377 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 18 | $18,897 |
| EntrestoSacubitril/Valsartan | 11 | $18,503 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $17,820 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 21 | $15,372 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $790 | $146,820136 claims |
| Lilly USA, LLCMounjaro, Trulicity | $82 | $95,67782 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $281 | $85,65572 claims |
| AstraZenecaFarxiga, Brilinta, Symbicort | $303 | $62,29075 claims |
| AbbVieLinzess, Vraylar | $193 | $54,58046 claims |
| PfizerEliquis | $605 | $50,49539 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $90 | $30,50838 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $140 | $18,89718 claims |
| NovartisEntresto | $33 | $18,50311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Quincy
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.